Inactivating FBXW7 mutations are common in cancers driven by NOTCH1 activating mutations, such as T-cell acute lymphoblastic leukaemia (T-ALL) and chronic lymphocytic leukaemia (CLL)31. Here, NOTCH1 is linked to B-cell chronic lymphocytic leukemia.